FK506 as effective adjunct to L-dopa in reserpine-induced catalepsy in rats

Indian Journal of Experimental Biology

Volumn 41, Issue 11, 2003, Pages 1264-1268

  Singh, Amanpreet ^a   Naidu, Pattipati S ^a   Kulkarni, Shrinivas K ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Catalepsy; FK506 adjunct; L dopa; Parkinson's disease; Reserpine induced catalepsy

Indexed keywords

DRUG THERAPY; NEUROLOGY;

NEUROPROTECTANTS;

DISEASE CONTROL;

ANTIPARKINSON AGENT; IMMUNOSUPPRESSIVE AGENT; LEVODOPA; RESERPINE; TACROLIMUS;

ANIMAL; ARTICLE; CATALEPSY; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG COMBINATION; FEMALE; MALE; RAT; WISTAR RAT;

ANIMALS; ANTIPARKINSON AGENTS; CATALEPSY; DRUG THERAPY, COMBINATION; FEMALE; IMMUNOSUPPRESSIVE AGENTS; LEVODOPA; MALE; RATS; RATS, WISTAR; RESERPINE; TACROLIMUS;

ANIMALIA;

EID: 0242627606     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Langston J, The etiology of Parkinson's disease with emphasis on the MPTP story, Neurology, Suppl 3 (1996) S153.
2. Marsden C, Broch O & Guldberg H, Effect of nigra and raphe lesions on catechol-O-methyltransferase and monoamine activities in the rat striatum, Eur J Pharmacol, 19 (1982) 35.
3. Aminoff M J, Pharmacological management of Parkinsonism and other movement disorders in basic and clinical pharmacology, international edition. edited by B G Katzung, (McGrawHill New York) 2001, 463.
4. Lang A E & Lozano A M, Parkinson's disease (review), Second of two parts, N Eng J Med, 339 (1998) 1130.
5. Gold B G, Katoh K, Storm-Dickerson T & Austin D R, The immunosuppressant FK506 increases the rate of axonal regeneration in rat sciatic nerves, J Neurosci, 15 (1995) 7509.
6. Tanaka K, Fujita N, Higashi Y & Ogawa N, Neuroprotective and antioxidant properties of FKBP-binding immunophilin ligands are independent on the FKBP12 pathway in human cells, Neurosci Lett, 330 (2002) 147.
7. Mogi M, Togari A, Tanaka K, Ogawa N, Ichinose H & Nagatsu T, Increase in level of tumor necrosis factor-alpha in 6-hydroxymine striatum lesioned rats is suppressed by immunosuppressant FK506, Neurosci Lett, 289 (2000) 165.
8. Sakanoue M, Mori N, Taka N, Kawai, M, Tani K, Suzuki K, Iwata Y, Sekine Y, Ashby CR Jr & Minabe Y, Tacrolimus a specific inhibitor of calcineurin, modifies locomotor activity of quinpirole, but not that of SKF 8298, in male rats, Eur J Pharmacol, 438(2002) 93.
9. Singh A & Kulkarni S K, Nitecapone and selegline as effective adjuncts to L-dopa in reserpine-induced catatonia in mice, Methods Find Exp Clin Pharmacol, 24 (2002) 23.
10. Fisher A, Biggs C S, Eradiri O & Starr M S, Dual effects of L-3,4-Dihydroxyphenylalanine on aromatic L-amino acid decarboxylase, dopamine release and motor stimulation in the reserpine-treated rat : evidence that behaviour is dopamine independent, Neuroscience 95 (2000) 97.
11. Stewart A & Pictor D O, Dopamine agonist, In The medical clinics of North America: Parkinson's disease and Parkinsonian syndromes, edited by B M Stern and H I Hurtig (W.B. Saunders, Philadelphia) 1999, 415.
12. Sharkey J & Butcher S P, Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischemia, Nature, 371 (1994) 336.
13. Sharkey J, Jones P A, McCarter J F & Kelly J S: Calcineurin inhibitors as neuroprotectants. Focus of tacrolimus and cyclosporine, CNS Drugs, 13 (2000) 1.
14. Hamilton G S, Huang W & Connolly M A, FKB12-binding domain analogues of FK506 are potent, nonimmunosupressive neurotropic agents in vitro and promote recovery in mouse model of Parkinson's disease, Bioorg Med Chem Lett, 1 (1997) 1785.
15. 2+-induced apoptosis through calcineurin dephosphorylation of BAD, Science, 284 (1999) 339.
16. 2+- activated cell death in mammalian cells, J Cell Biol, 131 (1995) 735.
17. Wolvetang E J, Larm J A, Moutsoulas P & Lawen A, Apoptosis induced by inhibitors of the plasma membrane NADH-oxidase involves Bcl-2 and calcineurin, Cell Growth. Differ, 7 (1996) 1315.
18. Sakai K, Date I, Yoshimoto Y, Arisawa T, Nakashima H, Furuta T, Asari S & Ohmoto T, The effect of a new immunosuppressive agent, FK506, on xenogeneic neural transplantation in rodents, Brain Res, 565 (1991) 167.
19. Kihara M, Kamijo M, Nakasaka Y, Mitsui M, Takahashi M & Schmelzer J. A small dose of the immunosuppressive agent FK506(Tacrolimus) protects peripheral nerve from ischemic fiber degeneration, Muscl. Nerve, 24 (2001) 1601.